These findings suggest that blocking receptor activation by endogenous LPA and S1P may be critical to the successful mobilization of either endogenous or exogenous neural progenitors for therapeutic recovery from neural injury or neurodegenerative disease. This evidence concerns the gene LPA and neurodegenerative disease.